Bob Pinedo, MD, PhD, retired in 2008 as Professor of Medical Oncology at the VU University Medical Center. He was the founder and Chairman of the Board of the VUmc Cancer Center Amsterdam where research and patient care are closely interwoven.
He has received many international awards including the prestigious Dr Josef Steiner Cancer Research Foundation Award (1995), the NOW Spinoza Price (1997) and recently the David A. Karnofsky Memorial Award of the American Society of Clinical Oncology (2014). In 2008 Dr. Pinedo has been decorated by H.M. Queen Beatrix of the Netherlands as Knight in the Order of the Netherlands Lion. He is a member of the Royal Dutch Academy of Science and Arts and has published over 700 research articles in peer-reviewed international journals.
Cancer research and care for cancer patients is Dr. Pinedo's big passion. He is a strong believer in the use of NK cell immunotherapy for treatment of cancer patients. His scientific expertise and comprehensive network will help Glycostem to signal opportunities for its technology and products in the treatment of cancer.
|Wim Jongen PhD, Wim has more than 25 years of experience in R&D and Business Development in life sciences. Wim has been active in the last 7 years as investment manager in Life Sciences, is currently active as chairman of the non-executive board of directors of NTRC B.V. and has acted as chairman of the board of directors of a number of Life Science companies.|